New Partners Provide Global Distribution for Expanding Demand for Aspect’s M2™ Desktop MRI System for Pre-Clinical Imaging
TORONTO, Canada, SHOHAM, Israel -- (April 18, 2011) Aspect Imaging today announced five new distributors who will sell and support it’s M2™ compact high-performance MRI imaging system across Asia in China, Japan, Taiwan and Korea and in Brazil. These new distributors will help Aspect meet increasing international demand by life science researchers for its M2™ imaging system.
Aspect Imaging ’s new world-class distributors are Winsun Limited in China, Primetech Corporation in Japan, SI Healthcare in Korea, Level Biotechnology Inc. in Taiwan and Ambriex S/A in Brazil. Each of these organizations maintains a highly trained team of application scientists, technical support specialists and a local sales and marketing team to effectively develop and support the sales of the M2 system to local academic and drug development researchers. As a result, In vivo demonstrations and scientific seminars on the M2 imaging system will soon be available across Asia.
“We are proud to announce our new distribution partners across Asia and in Brazil that will help us meet the growing global demand of our M2 imaging platform," says Uri Rapoport, Aspect Imaging’s Founder and CEO. “Each of our new partners has deep experience in pre-clinical imaging and talented staff that can provide excellent and responsive local support to customers in their respective markets”.
Aspect continues to distribute its M2 imaging system through its direct sales force in North America and Western Europe. The company also provides in vivo imaging training on the M2 system at key locations across North America and Europe, as well at its state-of-the-art training facility in Israel.
Full details and contact information for Aspect Imaging’s Distributors can be found at www.aspectimaging.com/distributor.
Aspect Imaging (www.aspectimaging.com) is the world’s leader in high-performance compact MRI imaging systems for preclinical, clinical and advanced industrial applications. In preclinical research, Aspect’s M2™ platform and suite of products enables academic researchers and pharmaceutical companies to harness the power and insights of MRI but without the cost, complexity and technical burden of traditional MRI systems. With Aspect’s integrated and simple-to-use platform, researchers can derive deep insights into their biological questions quickly, easily and cost-effectively - - and all with the push of a button. As the system has no fringe magnetic field, the M2 can be placed anywhere in a working lab including at a scientist’s benchtop. The M2™ platform is used by leading institutions for a broad range of in vivo, ex vivo and in vitro applications including high-resolution 3D anatomical, molecular, functional and multi-modality imaging. The Aspect high-performance MRI system is used to quantify the expression of disease, to monitor disease progression and to assess therapeutic efficacy and response.
T. +1 (416) 274 8166